Observes enzyme replacement therapy effects in people with Fabry disease
Observes people with Fabry disease who already receive enzyme replacement therapy.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease
Key facts
- Where
- Astrakhan, Barnaul, Borovichi, Chelyabinsk, Grozny, Gubkin, Irkutsk, Ivanovo, Kaa-Khem, Krasnodar, Kurgan, Omsk, Orenburg, Perm, Polevskoy, Rostov-on-Don, Ryazan, Saint Petersburg, Simferopol, Stavropol, Ufa, and Voronezh, RussiaSee the 23 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 65 years old?
Source: NCT06880250, who can take part
Where in Russia
- #13Astrakhan, RussiaNo longer taking part
- #27Barnaul, RussiaNo longer taking part
- #7Borovichi, RussiaNo longer taking part
- #6Chelyabinsk, RussiaNo longer taking part
- #21Grozny, RussiaNo longer taking part
- #16Gubkin, RussiaNo longer taking part
- #26Irkutsk, RussiaNo longer taking part
- #12Ivanovo, RussiaNo longer taking part
- #19Kaa-Khem, RussiaNo longer taking part
- #10Krasnodar, RussiaNo longer taking part
- #18Kurgan, RussiaNo longer taking part
- #17Omsk, RussiaNo longer taking part
- #15Orenburg, RussiaNo longer taking part
- #9Perm, RussiaNo longer taking part
- #23Polevskoy, RussiaNo longer taking part
- #2Rostov-on-Don, RussiaNo longer taking part
- #4Rostov-on-Don, RussiaNo longer taking part
- #24Ryazan, RussiaNo longer taking part
- #8Saint Petersburg, RussiaNo longer taking part
- #3Simferopol, RussiaNo longer taking part
- #22Stavropol, RussiaNo longer taking part
- #11Ufa, RussiaNo longer taking part
- #5Voronezh, RussiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- NPO Petrovax
- Trial code
- NCT06880250
- Record updated
- 31 December 2025
- Original description
The goal of this observational study is to learn how enzyme replacement therapy works in patients with Fabry disease. The main question it aims to answer is:Read full original descriptionShow less
Open-label Comparative Cohort Non-interventional Epidemiological Study of the Efficacy and Safety of Enzyme Replacement Therapy in Russian Patients With Fabry Disease
The goal of this observational study is to learn how enzyme replacement therapy works in patients with Fabry disease. The main question it aims to answer is:
What medical problems do participants have?
Participants already on enzyme replacement therapy as part of their regular medical care for Fabry disease will be observed as usual. Their data will be collected by their doctor.
Inclusion: Men and women with a confirmed diagnosis of Fabry disease; Prescribed course of enzyme replacement therapy with any drug (Fabagal, Fabrazyme, Replagal); Age 8 - 65 years; Signed informed consent of the patient and/or patient's legal representative for participation in the study and processing of personal data.
Exclusion: Renal replacement therapy or kidney transplantation; Critical illness unrelated to Fabry disease; Pregnancy or breastfeeding; Refusal of the patient (or patient's legal representative) from further participation in the study or medical care.